Literature DB >> 22948048

Acute silent cerebral ischemia and infarction during acute anemia in children with and without sickle cell disease.

Michael M Dowling1, Charles T Quinn, Patricia Plumb, Zora R Rogers, Nancy K Rollins, Korgun Koral, George R Buchanan.   

Abstract

We hypothesized that the silent cerebral infarcts (SCI), which affect up to 40% of children with sickle cell disease (SCD), could occur in the setting of acute anemic events. In a prospective observational study of children with and without SCD hospitalized for an illness associated with acute anemia, we identified acute silent cerebral ischemic events (ASCIE) in 4 (18.2%) of 22 with SCD and in 2 (6.7%) of 30 without SCD, using diffusion-weighted magnetic resonance imaging. Children with ASCIE had lower hemoglobin concentration than those without (median 3.1 vs 4.4 g/dL, P = .003). The unique temporal features of stroke on diffusion-weighted magnetic resonance imaging permit estimation of incidence rates for ASCIE of 421 (95% confidence interval, 155-920) per 100 patient-years during acute anemic events for all patients. For children with SCD, the estimated incidence was 663 (95% confidence interval, 182-1707) which is much higher than previously reported. Acute anemic events are common in children with SCD and prevalence could partially account for the high SCI. Some ASCIE (1 of 4 in our study) may be reversible. Alterations in management may be warranted for children with severe anemia to identify unrecognized ischemic brain injury that may have permanent neurocognitive sequelae.

Entities:  

Mesh:

Year:  2012        PMID: 22948048      PMCID: PMC3496951          DOI: 10.1182/blood-2012-01-406314

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  31 in total

1.  Time course of the apparent diffusion coefficient (ADC) abnormality in human stroke.

Authors:  G Schlaug; B Siewert; A Benfield; R R Edelman; S Warach
Journal:  Neurology       Date:  1997-07       Impact factor: 9.910

2.  MRI/MRA evaluation of sickle cell disease of the brain.

Authors:  Robert A Zimmerman
Journal:  Pediatr Radiol       Date:  2005-02-10

Review 3.  Risk factors and prediction of outcomes in children and adolescents who have sickle cell anemia.

Authors:  Charles T Quinn; Scott T Miller
Journal:  Hematol Oncol Clin North Am       Date:  2004-12       Impact factor: 3.722

4.  Cognitive functioning and brain magnetic resonance imaging in children with sickle Cell disease. Neuropsychology Committee of the Cooperative Study of Sickle Cell Disease.

Authors:  F D Armstrong; R J Thompson; W Wang; R Zimmerman; C H Pegelow; S Miller; F Moser; J Bello; A Hurtig; K Vass
Journal:  Pediatrics       Date:  1996-06       Impact factor: 7.124

5.  Cerebrovascular accidents in sickle cell disease: rates and risk factors.

Authors:  K Ohene-Frempong; S J Weiner; L A Sleeper; S T Miller; S Embury; J W Moohr; D L Wethers; C H Pegelow; F M Gill
Journal:  Blood       Date:  1998-01-01       Impact factor: 22.113

6.  Resolution of early diffusion-weighted and FLAIR MRI abnormalities in a patient with TIA.

Authors:  F E Lecouvet; T P Duprez; J M Raymackers; A Peeters; G Cosnard
Journal:  Neurology       Date:  1999-03-23       Impact factor: 9.910

Review 7.  Sickle cell disease.

Authors:  George R Buchanan; Michael R DeBaun; Charles T Quinn; Martin H Steinberg
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2004

8.  Silent cerebral infarcts in sickle cell anemia: a risk factor analysis. The Cooperative Study of Sickle Cell Disease.

Authors:  T R Kinney; L A Sleeper; W C Wang; R A Zimmerman; C H Pegelow; K Ohene-Frempong; D L Wethers; J A Bello; E P Vichinsky; F G Moser; D M Gallagher; M R DeBaun; O S Platt; S T Miller
Journal:  Pediatrics       Date:  1999-03       Impact factor: 7.124

9.  Alpha thalassemia and stroke risk in sickle cell anemia.

Authors:  R J Adams; A Kutlar; V McKie; E Carl; F T Nichols; J C Liu; K McKie; A Clary
Journal:  Am J Hematol       Date:  1994-04       Impact factor: 10.047

10.  Declining stroke rates in Californian children with sickle cell disease.

Authors:  Heather J Fullerton; Robert J Adams; Shoujun Zhao; S Claiborne Johnston
Journal:  Blood       Date:  2004-03-30       Impact factor: 22.113

View more
  34 in total

1.  Large-Vessel Vasculopathy in Children With Sickle Cell Disease: A Magnetic Resonance Imaging Study of Infarct Topography and Focal Atrophy.

Authors:  Kristin P Guilliams; Melanie E Fields; Dustin K Ragan; Yasheng Chen; Cihat Eldeniz; Monica L Hulbert; Michael M Binkley; James N Rhodes; Joshua S Shimony; Robert C McKinstry; Katie D Vo; Hongyu An; Jin-Moo Lee; Andria L Ford
Journal:  Pediatr Neurol       Date:  2016-12-07       Impact factor: 3.372

2.  Contribution of Sickle Cell Disease to the Pediatric Stroke Burden Among Hospital Discharges of African-Americans-United States, 1997-2012.

Authors:  Charlotte Baker; Althea M Grant; Mary G George; Scott D Grosse; Thomas V Adamkiewicz
Journal:  Pediatr Blood Cancer       Date:  2015-07-14       Impact factor: 3.167

3.  Parent education and biologic factors influence on cognition in sickle cell anemia.

Authors:  Allison A King; John J Strouse; Mark J Rodeghier; Bruce E Compas; James F Casella; Robert C McKinstry; Michael J Noetzel; Charles T Quinn; Rebecca Ichord; Michael M Dowling; J Philip Miller; Michael R Debaun
Journal:  Am J Hematol       Date:  2014-02       Impact factor: 10.047

4.  Interventions for preventing silent cerebral infarcts in people with sickle cell disease.

Authors:  Lise J Estcourt; Patricia M Fortin; Sally Hopewell; Marialena Trivella; Carolyn Doree; Miguel R Abboud
Journal:  Cochrane Database Syst Rev       Date:  2016-10

Review 5.  Interventions for preventing silent cerebral infarcts in people with sickle cell disease.

Authors:  Lise J Estcourt; Patricia M Fortin; Sally Hopewell; Marialena Trivella; Carolyn Doree; Miguel R Abboud
Journal:  Cochrane Database Syst Rev       Date:  2017-05-13

Review 6.  Advances in Understanding Ischemic Stroke Physiology and the Impact of Vasculopathy in Children With Sickle Cell Disease.

Authors:  Kristin P Guilliams; Melanie E Fields; Michael M Dowling
Journal:  Stroke       Date:  2019-02       Impact factor: 7.914

7.  Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia.

Authors:  Michael R DeBaun; Mae Gordon; Robert C McKinstry; Michael J Noetzel; Desiree A White; Sharada A Sarnaik; Emily R Meier; Thomas H Howard; Suvankar Majumdar; Baba P D Inusa; Paul T Telfer; Melanie Kirby-Allen; Timothy L McCavit; Annie Kamdem; Gladstone Airewele; Gerald M Woods; Brian Berman; Julie A Panepinto; Beng R Fuh; Janet L Kwiatkowski; Allison A King; Jason M Fixler; Melissa M Rhodes; Alexis A Thompson; Mark E Heiny; Rupa C Redding-Lallinger; Fenella J Kirkham; Natalia Dixon; Corina E Gonzalez; Karen A Kalinyak; Charles T Quinn; John J Strouse; J Philip Miller; Harold Lehmann; Michael A Kraut; William S Ball; Deborah Hirtz; James F Casella
Journal:  N Engl J Med       Date:  2014-08-21       Impact factor: 91.245

Review 8.  Current Standards of Care and Long Term Outcomes for Thalassemia and Sickle Cell Disease.

Authors:  Satheesh Chonat; Charles T Quinn
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

9.  Long-term Behavioral Problems in Children With Severe Malaria.

Authors:  John Mbaziira Ssenkusu; James Steven Hodges; Robert Opika Opoka; Richard Idro; Elsa Shapiro; Chandy Chiramukhathu John; Paul Bangirana
Journal:  Pediatrics       Date:  2016-10-05       Impact factor: 7.124

Review 10.  Sickle cell disease in childhood: from newborn screening through transition to adult medical care.

Authors:  Charles T Quinn
Journal:  Pediatr Clin North Am       Date:  2013-12       Impact factor: 3.278

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.